PortfoliosLab logoPortfoliosLab logo
BBC vs. BBH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBC vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and VanEck Vectors Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBC achieves a 23.79% return, which is significantly higher than BBH's 0.06% return. Over the past 10 years, BBC has outperformed BBH with an annualized return of 10.98%, while BBH has yielded a comparatively lower 7.19% annualized return.


BBC

1D
4.97%
1M
11.76%
YTD
23.79%
6M
18.79%
1Y
151.23%
3Y*
26.34%
5Y*
-0.15%
10Y*
10.98%

BBH

1D
0.92%
1M
2.50%
YTD
0.06%
6M
-1.66%
1Y
24.78%
3Y*
7.06%
5Y*
-0.40%
10Y*
7.19%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. BBH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBC
Virtus LifeSci Biotech Clinical Trials ETF
23.79%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%
BBH
VanEck Vectors Biotech ETF
0.06%21.18%-4.29%3.94%-15.25%11.81%22.13%26.34%-10.70%16.46%

Correlation

The correlation between BBC and BBH is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.59

Correlation (3Y)
Calculated over the trailing 3-year period

0.63

Correlation (5Y)
Calculated over the trailing 5-year period

0.68

Correlation (10Y)
Calculated over the trailing 10-year period

0.70

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2014

0.72

The correlation between BBC and BBH shifts across timeframes, from 0.59 (1 year) to 0.72 (all time), reflecting how their relationship changes across market environments.

BBC vs. BBH - Sectors Allocation Comparison


Sectors
BBC
BBH

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

BBC
100.0%
BBH
100.0%

Basic Materials

BBC

-

BBH

-

Communication Services

BBC

-

BBH

-

Consumer Cyclical

BBC

-

BBH

-

Consumer Defensive

BBC

-

BBH

-

Energy

BBC

-

BBH

-

Financial Services

BBC

-

BBH

-

Industrials

BBC

-

BBH

-

Real Estate

BBC

-

BBH

-

Technology

BBC

-

BBH

-

Utilities

BBC

-

BBH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBC vs. BBH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC
BBC Risk / Return Rank: 9494
Overall Rank
BBC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 9494
Sortino Ratio Rank
BBC Omega Ratio Rank: 9090
Omega Ratio Rank
BBC Calmar Ratio Rank: 9797
Calmar Ratio Rank
BBC Martin Ratio Rank: 9595
Martin Ratio Rank

BBH
BBH Risk / Return Rank: 3939
Overall Rank
BBH Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
BBH Sortino Ratio Rank: 3838
Sortino Ratio Rank
BBH Omega Ratio Rank: 3535
Omega Ratio Rank
BBH Calmar Ratio Rank: 4949
Calmar Ratio Rank
BBH Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and VanEck Vectors Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BBCBBHDifference
Sharpe ratioReturn per unit of total volatility

+2.91

Sortino ratioReturn per unit of downside risk

+2.66

Omega ratioGain probability vs. loss probability

1.55

1.23

+0.32

Calmar ratioReturn relative to maximum drawdown

10.08

2.36

+7.72

Martin ratioReturn relative to average drawdown

29.53

5.69

+23.84

BBC vs. BBH - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 4.20, which is higher than the BBH Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of BBC and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BBC vs. BBH - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, which is greater than BBH's maximum drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for BBC and BBH.


Loading charts...

Drawdown Indicators


BBCBBHDifference

Max Drawdown

Largest peak-to-trough decline

-76.85%

-72.70%

-4.15%

Max Drawdown (1Y)

Largest decline over 1 year

-15.10%

-10.55%

-4.55%

Max Drawdown (3Y)

Largest decline over 3 years

-54.45%

-22.74%

-31.71%

Max Drawdown (5Y)

Largest decline over 5 years

-71.97%

-39.86%

-32.11%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

-39.86%

-36.99%

Current Drawdown

Current decline from peak

-20.54%

-12.14%

-8.40%

Average Drawdown

Average peak-to-trough decline

-37.09%

-20.73%

-16.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

4.36%

+0.78%

Volatility

BBC vs. BBH - Volatility Comparison

Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 12.13% compared to VanEck Vectors Biotech ETF (BBH) at 6.13%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBCBBHDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.13%

6.13%

+6.00%

Volatility (6M)

Calculated over the trailing 6-month period

26.75%

14.61%

+12.14%

Volatility (1Y)

Calculated over the trailing 1-year period

36.33%

19.33%

+17.00%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.51%

21.44%

+18.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.79%

22.17%

+15.62%

BBC vs. BBH - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is higher than BBH's 0.35% expense ratio.


Dividends

BBC vs. BBH - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.37%, more than BBH's 0.51% yield.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.37%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
BBH
VanEck Vectors Biotech ETF
0.51%0.51%0.80%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%

Frequently Asked Questions


BBC and BBH have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBC has higher volatility (12.13%) compared to BBH (6.13%). In terms of maximum drawdown, BBC dropped -76.85% vs BBH's -72.70%.

On 10-year performance, BBC leads with 10.98% vs 7.19% for BBH. On fees, BBH is cheaper at 0.35% per year. On volatility, BBH has been the lower-risk option at 6.13%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, BBC has performed better with a 10.98% return vs 7.19%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BBH is cheaper with a 0.35% expense ratio, compared with 0.79% for BBC.

BBC has the higher dividend yield at 1.37%, compared with 0.51% for BBH.

BBC tracks LifeSci Biotechnology Clinical Trials Index, while BBH tracks MVIS US Listed Biotech 25 Index. They also come from different issuers: Virtus Investment Partners and VanEck. Their fees differ too: 0.79% for BBC and 0.35% for BBH.

BBC currently has the higher Sharpe Ratio (4.20 vs 1.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBC and BBH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer